G. Mangold

1.5k total citations
46 papers, 1.2k citations indexed

About

G. Mangold is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, G. Mangold has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 18 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in G. Mangold's work include Pancreatitis Pathology and Treatment (12 papers), Cancer Treatment and Pharmacology (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). G. Mangold is often cited by papers focused on Pancreatitis Pathology and Treatment (12 papers), Cancer Treatment and Pharmacology (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). G. Mangold collaborates with scholars based in Germany, United States and Canada. G. Mangold's co-authors include Daniel D. Von Hoff, Daniel L. Dexter, Helen M. Burt, Xichen Zhang, William L. Hunter, Drew Rasco, Shelly Gunn, Amita Patnaik, Kyriakos P. Papadopoulos and Theresa A. Mays and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

G. Mangold

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Mangold Germany 17 661 437 183 142 132 46 1.2k
Lorraine A. Cazenave United States 6 558 0.8× 847 1.9× 112 0.6× 95 0.7× 102 0.8× 7 1.3k
F. Zunino Italy 19 565 0.9× 514 1.2× 119 0.7× 59 0.4× 139 1.1× 33 1.2k
Yasuhide Hirota Japan 13 1.1k 1.6× 766 1.8× 197 1.1× 64 0.5× 111 0.8× 21 1.5k
Johann Rastetter Germany 18 590 0.9× 269 0.6× 189 1.0× 106 0.7× 54 0.4× 72 1.1k
Masashi Aonuma Japan 11 1.2k 1.8× 875 2.0× 128 0.7× 79 0.6× 118 0.9× 14 1.5k
Marie-Christine Bissery France 17 641 1.0× 641 1.5× 180 1.0× 123 0.9× 209 1.6× 41 1.4k
Barbara Caciagli Italy 7 382 0.6× 452 1.0× 252 1.4× 61 0.4× 97 0.7× 9 961
J. Liebmann United States 14 324 0.5× 548 1.3× 69 0.4× 117 0.8× 218 1.7× 19 1.2k
Vessela Vassileva United Kingdom 14 404 0.6× 466 1.1× 96 0.5× 130 0.9× 58 0.4× 21 1.1k
HM Pinedo Netherlands 16 567 0.9× 691 1.6× 53 0.3× 54 0.4× 119 0.9× 20 1.3k

Countries citing papers authored by G. Mangold

Since Specialization
Citations

This map shows the geographic impact of G. Mangold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Mangold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Mangold more than expected).

Fields of papers citing papers by G. Mangold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Mangold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Mangold. The network helps show where G. Mangold may publish in the future.

Co-authorship network of co-authors of G. Mangold

This figure shows the co-authorship network connecting the top 25 collaborators of G. Mangold. A scholar is included among the top collaborators of G. Mangold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Mangold. G. Mangold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimizu, Toshio, Anthony W. Tolcher, Kyriakos P. Papadopoulos, et al.. (2012). The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer. Clinical Cancer Research. 18(8). 2316–2325. 352 indexed citations
2.
Izbicka, Elżbieta, et al.. (2006). Molecular determinants of differential sensitivity to docetaxel and paclitaxel in human pediatric cancer models.. PubMed. 26(3A). 1983–8. 15 indexed citations
3.
Mangold, G., et al.. (2005). Tinnitus bei craniomandibulärer Dysfunktion. Manuelle Medizin. 43(6). 414–417.
4.
Mangold, G., et al.. (2004). Verlaufsvariet�ten des Nervus laryngeus inferior. Der Chirurg. 75(2). 187–195. 17 indexed citations
5.
Mangold, G., et al.. (2003). Die Nebenmilz im Pankreasschwanz?eine vernachl�ssigte Entit�t?. Der Chirurg. 74(12). 1170–1177. 10 indexed citations
6.
Hao, Desirée, Jinee Rizzo, Daniel L. Dexter, et al.. (2002). Preclinical Antitumor Activity and Pharmacokinetics of Methyl-2-Benzimidazolecarbamate (FB642). Investigational New Drugs. 20(3). 261–270. 34 indexed citations
7.
Mangold, G., et al.. (2002). Ergebnisse der Behandlung des Sinus pilonidalis durch Schwenklappenplastik nach Limberg. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 127(8). 712–715. 11 indexed citations
8.
Mangold, G., et al.. (2001). Der fibrovasculäre Oesophaguspolyp – Diagnostik und Therapie. Der Chirurg. 72(7). 847–852. 6 indexed citations
9.
Riemer, Angelika B., et al.. (2000). Das rupturierte Aneurysma der Arteria pancreaticoduodenalisEine seltene Ursache des akuten Abdomens. Der Chirurg. 71(10). 1285–1287. 2 indexed citations
10.
Hammond, L. A., Susan G. Hilsenbeck, Sabine Eckhardt, et al.. (2000). Enhanced antitumour activity of 6-hydroxymethylacylfulvene in combination with topotecan or paclitaxel in the MV522 lung carcinoma xenograft model. European Journal of Cancer. 36(18). 2430–2436. 25 indexed citations
11.
Weitman, Steven, G. Mangold, Daniel L. Dexter, et al.. (1999). Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft. Cancer Chemotherapy and Pharmacology. 43(5). 402–408. 16 indexed citations
12.
Raymond, Éric, D. Sun, Elżbieta Izbicka, et al.. (1999). A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay. British Journal of Cancer. 80(9). 1332–1341. 19 indexed citations
13.
Morgan, Amy S., Richard F. Borch, Kenneth D. Tew, et al.. (1998). Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase.. PubMed. 58(12). 2568–75. 59 indexed citations
14.
Mangold, G., et al.. (1997). Traumatische arteriovenöse Fistel zwischen Arteria und Vena thyreoidea superior. Der Chirurg. 68(12). 1304–1306. 2 indexed citations
15.
Zhang, Xichen, Helen M. Burt, Daniel D. Von Hoff, et al.. (1997). An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel. Cancer Chemotherapy and Pharmacology. 40(1). 81–86. 91 indexed citations
16.
Kümmerle, F., G. Mangold, & K. Rückert. (1979). [Surgery of the pancreas. Chronic pancreatitis, pancreatic carcinoma, endocrine pancreatic tumors].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(8). 399–406. 3 indexed citations
17.
Kümmerle, F., G. Mangold, & K. Rückert. (1978). [Life and life expectancy following surgery of the pancreas].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(2). 34–40. 3 indexed citations
18.
Kümmerle, F., et al.. (1977). [Delayed surgery in acute pancreatitis].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 48(7). 439–43. 4 indexed citations
19.
Mangold, G.. (1977). [Chronic pancreatitis--the current state of surgical treatment].. PubMed. 15(2). 76–88. 1 indexed citations
20.
Kümmerle, F., et al.. (1973). [Surgical treatment of chronic pancreatitis].. PubMed. 28(11). 1091–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorraine A. Cazenave Breakdown of academic impact, for papers by F. Zunino Breakdown of academic impact, for papers by Yasuhide Hirota Breakdown of academic impact, for papers by Johann Rastetter Breakdown of academic impact, for papers by Masashi Aonuma Breakdown of academic impact, for papers by Marie-Christine Bissery Breakdown of academic impact, for papers by Barbara Caciagli Breakdown of academic impact, for papers by J. Liebmann Breakdown of academic impact, for papers by Vessela Vassileva Breakdown of academic impact, for papers by HM Pinedo
Rankless by CCL
2026